the microsampling blog

In the US, use of the Mitra device is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device can be used as a sample collection device for clinical diagnostic applications, as referenced in some content.

saliva microsampling: lessons from COVID-19

by Neoteryx | 3 min read

shutterstock_1058554262The COVID-19 pandemic has provided researchers with a unique opportunity to explore several different types of bio-fluid collection and testing. The crisis has helped experts understand which methods work best in different settings, scenarios and studies. 

Nasopharyngeal (NP) swabs for RT-PCR testing have served as the first-line method for detecting active infection with COVID-19 during the coronavirus pandemic. This method is effective and relatively easy to administer, but it is also very uncomfortable and difficult to conduct on children and some patients with disabilities. The NP swab method also has produced frequent false-negative results and has led to some complications.

Researchers also have used blood samples for serology studies to determine if people who have recovered from COVID-19 have developed antibodies against the SARS-CoV-2 virus. Due to widespread lockdowns and safety concerns during the coronavirus pandemic, many researchers have obtained samples remotely using Mitra® devices for microsampling studies. Blood testing has been the dominant method used to examine both natural and vaccine-induced immunity response to SARS-CoV-2

Researchers also used saliva testing during the pandemic. The ease of use and results of some SARS-CoV-2 saliva sampling studies have generated significant interest in this type of bio-fluid testing. Saliva testing is certainly more comfortable and convenient for study participants. In one study by researchers at Yale School of Medicine, saliva was found to better predict the severity of COVID-19 disease progression in individuals. This was because the saliva samples collected for this study provided better estimates of viral load compared to other bio-fluid samples. 

A New Frontier for Bio-fluid Testing

Saliva testing in research has traditionally been challenging due to a lack of sufficiently powerful lab equipment. Analyzing the full spectrum of biomarkers present in saliva requires sensitivity between 1,000-10,000 times higher than what older equipment is typically capable of. Newer equipment is much more powerful, and now that these newer models have started to become more widely available in laboratories, saliva testing also has become more viable. 

Researchers are still exploring what kinds of information they can derive from saliva sampling and testing, but early applications suggest it can be used to uncover at least as much biological information as most other bio-fluid testing. It may also be useful in detecting conditions that are not currently screened with bio-fluids, including concussions.

How Saliva Sampling Works 

Because researchers can extract all the biological information they need from very small saliva samples, saliva microsampling can work well in many studies. With microsampling, the sample collection process can be conducted remotely or in-person using microsampling devices such as Mitra® devices with VAMS® technology. These devices can be sent to study participants at home in Mitra collection kits, which contain all the supplies needed for sample collection. This is a simple user-centric process that allows trial subjects to self-collect samples at any time and in any setting they choose. 

In clinical trials that offer a remote option for participation, the trial subject typically receives a specimen collection kit in the mail and unpacks the collection devices and other supplies. For saliva collection, a sputum cup will be enclosed. Trial subjects must spit into the cup several times to amass a small pool of saliva. The subject then holds the tip of each of their two Mitra devices in the saliva for about 2 seconds. Once the device tips are filled with the saliva specimens, the devices are closed inside their protective casing, which is sealed into a pouch and a prepaid envelope, and mailed back to the lab for analysis. 

The entire sample collection process takes just a few minutes from start to finish and can be performed by anyone following the simple instructions provided. This sampling method greatly expands the possible applications for saliva testing in a range of research studies. 

Future Applications of Saliva Sampling 

Saliva sampling may be used for new applications in the future, which may provide new insights. For example, there are many diseases that don’t shed biomarkers in blood, but may shed them in saliva. Using saliva sampling could help researchers and clinicians test for and treat illnesses that are currently difficult to detect using blood testing alone. Saliva testing also has potential in toxicology applications and may present an attractive alternative to messy drug and alcohol tests, such as urine testing.

There are also situations in which saliva microsampling may offer unique advantages over other methods. For instance, saliva microsampling can be used to test for HIV with nearly the same level of precision as blood testing, while providing a more comfortable user experience. Saliva sampling can also minimize the risk of accidental disease transmission. 

Exploring Saliva’s Potential 

The full range of possibilities for saliva sampling remains untapped, but after the promise it showed during the COVID-19 pandemic, it merits further investigation. The non-invasive comfort and convenience of saliva microsampling vs. more invasive specimen sampling suggests that more sampling applications of this bio-fluid are worth implementing on a wider scale. 

infectious disease resource bundle

Originally published Jun 21, 2021 9:00:00 AM, updated on June 21, 2021

Comments

Learn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!

search our blog

social media

subscribe to the blog